Rapport Therapeutics, Inc. (RAPP) Deep Dive Video

Summary

Rapport offers a high-risk, high-upside precision neuroscience story built on RAP-219’s differentiated seizure-control profile, strong cash runway, and approaching Phase 3 catalysts.

View RAPP stock page · Read the RAPP research report

Loading the video player…